Brigitte Pützer

Prof. Brigitte Pützer

1. Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Center, 18057 Rostock, Germany
+1

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Theranostics
Verified
Journal Article
Open access
SLStella Logotheti
Stella Logotheti
SMStephan Marquardt
Stephan Marquardt
SGShailendra K. Gupta
Shailendra K. Gupta
CRChristin Richter
Christin Richter
BEBerdien A.H. Edelhäuser
Berdien A.H. Edelhäuser
Brigitte PützerBrigitte Pützer
Brigitte Pützer
Long non-coding RNAs (lncRNAs) have emerged as integral components of E2F1-regulated gene regulatory networks (GRNs), but their implication in advanced or treatment-refractory malignancy is unknown.

1 October 2013 in Cancer Cell
Verified
Journal Article
Closed access
MSMarc Steder
Marc Steder
VAVijay Alla
Vijay Alla
CMClaudia Meier
Claudia Meier
ASAlf Spitschak
Alf Spitschak
Jens PahnkeJens Pahnke
Jens Pahnke
Brigitte PützerBrigitte Pützer
Brigitte Pützer

1 February 2013 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
Brigitte PützerBrigitte Pützer
Brigitte Pützer
DEDavid Engelmann
David Engelmann

15 August 2012 in Cell Cycle
Verified
Journal Article
Open access
VAVijay Alla
Vijay Alla
BKBhavani S. Kowtharapu
Bhavani S. Kowtharapu
DEDavid Engelmann
David Engelmann
SEStephan Emmrich
Stephan Emmrich
USUlf Schmitz
Ulf Schmitz
Brigitte PützerBrigitte Pützer
Brigitte Pützer
Resistance to anti-neoplastic agents is the major cause of therapy failure, leading to disease recurrence and metastasis. E2F1 is a strong inducer of apoptosis in response to DNA damage through its...

1 December 2018 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
SMStephan Marquardt
Stephan Marquardt
MSManish Solanki
Manish Solanki
ASAlf Spitschak
Alf Spitschak
Julio VeraJulio Vera
Julio Vera
Brigitte PützerBrigitte Pützer
Brigitte Pützer

23 October 2014 in EMBO Reports
Verified
Journal Article
Open access
PDF file
SKSusanne Knoll
Susanne Knoll
KFKatharina Fürst
Katharina Fürst
BKBhavani Kowtharapu
Bhavani Kowtharapu
USUlf Schmitz
Ulf Schmitz
SMStephan Marquardt
Stephan Marquardt
Brigitte PützerBrigitte Pützer
Brigitte Pützer
Malignant melanoma is highly lethal due to its aggressive invasive properties and metastatic dissemination. The transcription factor E2F1 is crucial for melanoma progression through poorly understood mechanisms. Here, we show that the miR‐224/miR‐452 cluster is significantly increased in advanced melanoma and invasive/metastatic cell lines that express high levels of E2F1. miR‐224/miR‐452 expression is directly activated by E2F1 through transactivation of the GABRE gene. Ectopic expression of miR‐224/miR‐452 in less aggressive cells induces EMT and cytoskeletal rearrangements and enhances migration/invasion. Conversely, miR‐224/miR‐452 depletion in metastatic cells induces the reversal of EMT, inhibition of motility, loss of the invasive phenotype and an absence of lung metastases in mice. We identify the metastasis suppressor TXNIP as new target of miR‐224/miR‐452 that induces feedback inhibition of E2F1 and show that miR‐224/452‐mediated downregulation of TXNIP is essential for E2F1‐induced EMT and invasion. The E2F1‐miR‐224/452‐TXNIP axis constitutes a molecular signature that predicts patient survival and may help to set novel therapies. Synopsis The E2F1‐miR‐244/452‐TXNIP pathway is shown to be crucial for melanoma invasion and metastasis in vivo. By activating the expression of miR‐224/452, E2F1 leads to the downregulation of its inhibitor, TXNIP, and induces EMT. In early primary tumors, high levels of TXNIP restrict E2F1 activity through p16 activation and subsequent inhibition of RB. Increasingly high levels of E2F1 during cancer progression lead to the transcriptional upregulation of the miR‐224/452 cluster. miR‐224 and miR‐452 repress the expression of TXNIP to induce E2F1‐dependent EMT and invasion.